Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects

Diabetes, Metabolic Syndrome and Obesity

Volumn 5, Issue , 2012, Pages 21-27

  Vinson, Joe A ^a   Burnham, Bryan R ^a   Nagendran, Mysore V ^b  

^a UNIVERSITY OF SCRANTON   (United States)

^b Health Sciences   (India)

Author keywords

Blood pressure; Body fat mass; Body mass index; Chlorogenic acid; Green coffee bean extract; Heart rate; Weight loss

Indexed keywords

GCA; GREEN COFFEE BEAN EXTRACT; NUTRACEUTICAL; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY FAT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HEART RATE; HUMAN; LOW DRUG DOSE; MALE; NORMAL VALUE; OBESITY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; WEIGHT REDUCTION;

EID: 84857094415     PISSN: None     EISSN: 11787007     Source Type: Journal    
DOI: 10.2147/dmso.s27665     Document Type: Article

References (28)

1. World Health Organization (WHO). Fact Sheet 311. Geneva: WHO; 2011.
2. Market Research News. Global market for weight loss worth US$586.3 billion by 2014. Available from: http://www.salisonline.org/market-research/global-market-for-weight-loss-worth-us586-3-billionby-2014/. Accessed November 18, 2011.
3. Vinson JA, Al Kharrat H, Shuta D. Investigation of an amylase inhibitor on human glucose absorption after starch consumption. Open Nutraceuticals J. 2009;2:88-91.
4. Barrett ML, Udani JK. A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control. Nutr J. 2011;10:24.
5. Lopez-Garcia E, van Dam RM, Rajpathak S, Willett WC, Manson JE, Hu FB. Changes in caffeine intake and long-term weight change in men and women. Am J Clin Nutr. 2006;83:674-680.
6. St-Onge MP, Salinardi T, Herron-Rubin K, Black RM. A weight-loss diet including coffee-derived mannooligosaccharides enhances adipose tissue loss in overweight men but not women. Obesity (Silver Spring). September 22, 2011. [Epub ahead of print.]
7. Choi EY, Park SY, Cho YO. Freeze-dried instant coffee can promote the activities of antioxidant enzymes and induce weight loss but also aggravate the plasma cholesterol profile in rats. Nutrition. 2011;2:1202-1205.
8. Heckman MA, Weil J, Gonzalez de Mejia E. Caffeine (1,3,7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci. 2010;75:R77-R87.
9. Dennis EA, Flack KD, Davy BM. Beverage consumption and adult weight management: A review. Eat Behav. 2009;10:237-246.
10. Greenberg JA, Boozer CN, Geliebter A. Coffee, diabetes, and weight control. Am J Clin Nutr. 2006;84:682-693.
11. Stohs SJ, Preuss HG, Keith SC, Keith PL, Miller H, Kaats GR. Effects of p-synephrine alone and in combination with selected bioflavonoids on resting metabolism, blood pressure, heart rate and self-reported mood changes. Int J Med Sci. 2011;8:295-301.
12. Narita Y, Inouye KJ. Kinetic analysis and mechanism on the inhibition of chlorogenic acid and its components against porcine pancreas alpha-amylase isozymes I and II. J Agric Food Chem. 2009;57: 9218-9225.
13. Rodriguez de Sotillo DV, Hadley T, Sotillo JE. Insulin receptor exon 11+/- is expressed in Zucker (fa/fa) rats, and chlorogenic acid modifies their plasma insulin and liver protein and DNA. J Nutr Biochem. 2006;7:63-71.
14. Rodriguez de Sotillo DV, Hadley M. Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats, J Nutr Biochem. 2002;13:717-726.
15. Johnston KL, Clifford MN, Morgan LM. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr. 2003;78:728-733.
16. Almoosawi S, McDougall GJ, Fyfe L, et al. Nutrition Bulletin. 2010;35: 207-323.
17. Superko HR, Bortz W Jr, Williams PT, Albers JJ, Wood PD. Caffeinated and decaffeinated coffee effects on plasma lipoprotein cholesterol, apolipoproteins, and lipase activity: a controlled, randomized trial. Am J Clin Nutr. 1991;54:599-605.
18. Shimoda H, Seki E, Aitani M. Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice. BMC Complement Altern Med. 2006;6:9.
19. Murase T, Misawa K, Minegishi Y, et al. Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice. Am J Physiol Endocrino Metab. 2011; 300:E122-E133.
20. Li SY, Chang CQ, Ma FY, Yu CL. Modulating effects of chlorogenic acid on lipids and glucose metabolism and expression of hepatic peroxisome proliferator-activated receptor-alpha in golden hamsters fed on high fat diet. Biomed Environ Sci. 2009;22:122-129.
21. Thom E. A randomized, double-blind, placebo-controlled trial of a new weight-reducing agent of natural origin. J Int Med Res. 2000;28:229-233.
22. Dellaibera B, Lemaire S, Lafay S. Svetol, green coffee extract, induces weight loss and increases the lean to fat mass ratio in volunteers with overweight problem. Phytotherapie. 2006;4:194-197.
23. Bakuradze T, Boehm N, Janzowski C, et al. Antioxidant-rich coffee reduces DNA damage, elevates glutathione status and contributes to weight control: results from the intervention study. Mol Nutr Food Res. 2011;55:793-797.
24. Onakpova I, Terry R, Ernst E. The use of green coffee extract as a weight loss supplement: a systematic review and meta-analysis of randomized clinical trials. Gastroenterol Res Pract. 2011:2011.
25. Guaraldi F, Pagotto U, Pasqual R. Predictors of weight loss and maintenance in patients treated with antiobesity drugs. Diabetes Metab Syndr Obes. 2011;4:229-243.
26. Rucker D, Padwal R, Li SK, Curioni C, Lau DC. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ. 2007;335:1194-1199.
27. WHO. Obesity: preventing and managing the global epidemic. Geneva, Switzerland: Report of a WHO consultation. Technical Report Series. 2000:894.
28. Hemo B, Endevelt R, Porath A, Stampfer MJ, Shai I. Adherence to weight loss medications; post-marketing study from HMO pharmacy data of one million individuals. Diabetes Res Clin Pract. September 8, 2011. [Epub ahead of print.]